
Biotech Company Co-funded by Edinburgh Scientists Raise $42.5 million to Treat Sight Loss
Gemini Therapeutics, received $42.5 million through a Series A funding round to develop their research in dry age-related macular degeneration (Dry...
Do you have news for the Scottish Life Sciences Community?
Submit Your Own News